ERK1/2 activation attenuates TRAIL-induced apoptosis through the regulation of mitochondria-dependent pathway

Toxicology in Vitro

Volumn 20, Issue 6, 2006, Pages 816-823

  Lee, Do Yeon ^a   Lee, Myoung Woo ^a   Lee, Hyun Jung ^a   Noh, Yoo Hun ^a   Park, Soon Cheol ^a   Lee, Moo Yeol ^a   Kim, Kyung Yong ^a   Lee, Won Bok ^a   Kim, Sung Su ^a,b  

^a Chung Ang University   (South Korea)

^b BioGrand Inc   (South Korea)

Author keywords

Apoptosis; Bcl 2 Bax; Cytochrome c; Extracellular signal regulated kinase 1 2; Tumor necrosis factor related apoptosis inducing ligand

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; CASPASE; CYTOCHROME C; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAX; PROTEIN BCL 2; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DAMAGE; CELL DEATH; CELL LINE; CELL MEMBRANE POTENTIAL; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOPLASM; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOLECULAR DYNAMICS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRESS; TUMOR CELL; UPREGULATION;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL SURVIVAL; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HELA CELLS; HUMANS; MEMBRANE GLYCOPROTEINS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745188454     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2006.01.007     Document Type: Article

References (35)

1. Annis M.G., Zamzami N., Zhu W., Penn L.Z., Kroemer G., Leber B., and Andrews D.W. Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event. Oncogene 12 (2001) 1939-1952
2. Antonsson B., Conti F., Civatta A., Montessuit S., Lewis S., Martinou I., Bernasconi L., Bernard A., Mermod J.J., Mazzei G., Maundrell K., Gambale F., Sadoul R., and Martinou J.C. The Bcl-2 protein family. Science 18 (1997) 370-372
3. Bhat N.R., and Zhang P. Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72 (1999) 112-119
4. Boucher M.J., Morisset J., Vachon P.H., Reed J.C., Laine J., and Rivard N. MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells. J. Cell. Biochem. 79 (2000) 355-369
5. Cain K. Chemical-induced apoptosis: formation of the Apaf-1 apoptosome. Drug Metab. Rev. 35 (2003) 337-363
6. Chang L., and Karin M. Mammalian MAP kinase signalling cascades. Nature 410 (2001) 37-40
7. Desire L., Courtois Y., and Jeanny J.C. Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal Bcl-x(L) and Bcl-2 expression through a fibroblast berowth factor receptor 1- and ERK-dependent pathway. J. Neurochem. 75 (2000) 151-163
8. Domen J., Gandy K.L., and Weissman I.L. Systemic overexpression of Bcl-2 in the hematopoietic system protects transgenic mice from the consequences of lethal irradiation. Blood 91 (1998) 2272-2282
9. Fulda S., Meyer E., and Debatin K.M. Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression. Oncogene 21 (2002) 2283-2294
10. + increases alpha-synuclein expression and ERK/MAP-kinase phosphorylation in human neuroblastoma SH-SY5Y cells. Brain Res. 935 (2002) 32-39
11. Gonzalez-Polo R.A., Soler G., Alonso J.C., Rodriguez-Martin A., and Fuentes J.M. MPP(+) causes inhibition of cellular energy supply in cerebellar granule cells. Neurotoxicology 24 (2003) 219-225
12. Jiang X., and Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J. Biol. Chem. 275 (2000) 31199-31203
13. Kelley S.K., and Ashkenazi A. Targeting death receptors in cancer with Apo2L/TRAIL. Curr. Opin. Pharmacol. 4 (2004) 333-339
14. Keogh S.A., Walczak H., Bouchier-Hayes L., and Martin S.J. Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis. FEBS Lett. 471 (2000) 93-98
15. Kim M.S., So H.S., Park J.S., Lee K.M., Moon B.S., Lee H.S., Kim T.Y., Moon S.K., and Park R. Hwansodan protects PC12 cells against serum-deprivation-induced apoptosis via a mechanism involving Ras and mitogen-activated protein (MAP) kinase pathway. Gen. Pharmacol. 34 (2000) 227-235
16. Knight M.J., Riffkin C.D., Muscat A.M., Ashley D.M., and Hawkins C.J. Analysis of FasL and TRAIL induced apoptosis pathways in glioma cells. Oncogene 13 (2001) 5789-5798
17. Lee M.W., Park S.C., Yang Y.G., Yim S.O., Chae H.S., Bach J.H., Lee H.J., Kim K.Y., Lee W.B., and Kim S.S. The involvement of reactive oxygen species (ROS) and p38 mitogen-activated protein (MAP) kinase in TRAIL/Apo2L-induced apoptosis. FEBS Lett. 512 (2002) 313-318
18. Matsuda T., Almasan A., Tomita M., Uchihara J.N., Masuda M., Ohshiro K., Takasu N., Yagita H., Ohta T., and Mori N. Resistance to Apo2 ligand (Apo2L)/tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis and constitutive expression of Apo2L/TRAIL in human T-cell leukemia virus type 1-infected T-cell lines. J. Virol. 79 (2005) 1367-1378
19. Merienne K., Jacquot S., Zeniou M., Pannetier S., Sassone-Corsi P., and Hanauer A. Activation of RSK by UV-light: phosphorylation dynamics and involvement of the MAPK pathway. Oncogene 19 (2000) 4221-4229
20. Nagata Y., and Todokoro K. Requirement of activation of JNK and p38 for environmental stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis. Blood 94 (1999) 853-863
21. Nakshatri H., Rice S.E., and Bhat-Nakshatri P. Antitumor agent parthenolide reverses resistance of breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through sustained activation of c-Jun N-terminal kinase. Oncogene 23 (2004) 7330-7344
22. Park S.A., Park H.J., Lee B.I., Ahn Y.H., Kim S.U., and Choi K.S. Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Brain Res. Mol. Brain Res. 93 (2001) 18-26
23. Purring-Koch C., and McLendon G. Cytochrome c binding to Apaf-1: the effects of dATP and ionic strength. Proc. Natl. Acad. Sci. USA 97 (2000) 11928-11931
24. Schaeffer H.J., and Weber M.J. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol. Cell. Biol. 19 (1999) 2435-2444
25. She Q.B., Chen N., and Dong Z. ERKs and p38 kinase phosphorylate p53 protein at serine 15 in response to UV radiation. J. Biol. Chem. 275 (2000) 20444-20449
26. Srivastava R.K., Sasaki C.Y., Hardwick J.M., and Longo D.L. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. J. Exp. Med. 190 (1999) 253-265
27. Stanciu M., Wang Y., Kentor R., Burke N., Watkins S., Kress G., Reynolds I., Klann E., Angiolieri M.R., Johnson J.W., and DeFranco D.B. Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275 (2000) 12200-12206
28. Sun S.Y., Yue P., Zhou J.Y., Wang Y., Choi Kim H.R., Lotan R., and Wu G.S. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Biochem. Biophys. Res. Commun. 280 (2001) 788-797
29. Takahashi M., Saito H., Okuyama T., Miyashita T., Kosuga M., Sumisa F., Yamada M., Ebinuma H., and Ishii H. Overexpression of Bcl-2 protects human hepatoma cells from Fas-antibody-mediated apoptosis. J. Hepatol. 31 (1999) 315-322
30. Tran S.E., Holmstrom T.H., Ahonen M., Kahari V.M., and Eriksson J.E. MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 11 (2001) 16484-16490
31. Tsai E.Y., Falvo J.V., Tsytsykova A.V., Barczak A.K., Reimold A.M., Glimcher L.H., Fenton M.J., Gordon D.C., Dunn I.F., and Goldfeld A.E. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol. Cell. Biol. 20 (2000) 6084-6094
32. Tsukada Y., Miyazawa K., and Kitamura N. High intensity ERK signal mediates hepatocyte growth factor-induced proliferation inhibition of the human hepatocellular carcinoma cell line HepG2. J. Biol. Chem. 276 (2001) 40968-40976
33. Walczak H., Miller R.E., Ariail K., Gliniak B., Griffith T.S., Kubin M., Chin W., Jones J., Woodward A., Le T., Smith C., Smolak P., Goodwin R.G.., Rauch C.T., Schuh J.C., and Lynch D.H. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat. Med. 5 (1999) 157-163
34. Wilson D.J., Alessandrini A., and Budd R.C. MEK1 activation rescues Jurkat T cells from Fas-induced apoptosis. Cell. Immunol. 194 (1999) 67-77
35. Yagita H., Takeda K., Hayakawa Y., Smyth M.J., and Okumura K. TRAIL and its receptors as targets for cancer therapy. Cancer Sci. 95 (2004) 777-783